title: Periodic presumptive treatment for women with prevalent vaginal infections: secondary analysis of data from a randomized controlled trial.
authors.affiliation: Department of Epidemiology, University of Washington, Seattle, WA Departments of Epidemiology, Global Health, and Medicine, University of Washington, Seattle, WA Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA Department of Global Health, University of Washington, Seattle, WA jbalkus@fhcrc.org.
authors.forename: Vernon
authors.initials: V
authors.lastname: Mochache
authors.forename: Raymond Scott
authors.initials: RS
authors.lastname: McClelland
authors.forename: Jennifer E
authors.initials: JE
authors.lastname: Balkus
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy* / Q000517:prevention & control; D018890:Chemoprevention / Q000379:methods; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use*; D006801:Humans; D007630:Kenya; D008795:Metronidazole / Q000627:therapeutic use*; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D060386:Sex Workers; D016896:Treatment Outcome; D014247:Trichomonas Vaginitis / Q000188:drug therapy* / Q000517:prevention & control; D016585:Vaginosis, Bacterial / Q000188:drug therapy* / Q000517:prevention & control
chemical_list: D000890:Anti-Infective Agents; D008795:Metronidazole; D015725:Fluconazole